NOTE 11. – LOSS PER COMMON SHARE The following table sets forth the computation of basic and diluted loss per common share for the three months ended March 31, 2025 and 2024, respectively. Outstanding warrants, options and RSUs were excluded from the calculation of diluted EPS as the effect was antidilutive to consolidated net loss. 8,519 pre-funded warrants are included in weighted average common shares outstanding – basic and diluted for purposes of calculating loss per common share for the three month period ended March 31, 2025. | | | | | | | | | Three Months Ended | | | March 31, | | | 2025 | | 2024 | | | | | | | | Net loss from continuing operations | | $ | (3,274) | | $ | (5,450) | Net loss from discontinued operations | | | (1,054) | | | (289) | Net loss | | | (4,328) | | | (5,739) | Deemed dividends | | | — | | | (3,589) | Net loss available to common shareholders | | $ | (4,328) | | $ | (9,328) | | | | | | | | Basic and diluted loss per common share from continuing operations | | $ | (1.89) | | $ | (230.82) | Basic and diluted loss per common share from discontinued operations | | | (0.61) | | | (12.25) | Basic and diluted loss per common share from deemed dividends | | | — | | | (152.00) | Basic and diluted loss per common share | | $ | (2.50) | | $ | (395.07) | | | | | | | | Anti-dilutive shares are as follows as of March 31: | | | | | | | Warrants (excluding pre-funded) | | | 23,906,256 | | | 28,192 | Options | | | 478,777 | | | 78 | Restricted stock units | | | 159,583 | | | 33 | | | | 24,544,616 | | | 28,303 |
|